Should it be adopted in early April 2014, the new Regulation on clinical trials could establish greater transparency on clinical trials data and results.
Both associations share a common goal: reducing healthcare fraud, waste and corruption in Europe.
AIM members express their views on the European Commission Communication on Social Investment Package, Investing in Health and Long-term care Staff Working Documents
In their memorandum MIEF highlights its prospects for the next parliamentary term, underlining the prevalence of public health over the private sector's interests.
Providing quality care remains a challenge among Member States and it is their duty to provide high quality care. The Commission’s communication highlights a number of initiatives through which...
On 3 and 4 April 2014, the EU Commission held a Summit on Chronic Diseases. Mr Sinisa Varga, Chair of the AIM Disease Management Working Group spoke at the event.
|April - 2014|